Abstract
Switching from a metered-dose inhaler (MDI) to a dry powder inhaler (DPI) more than halved patients’ inhaler carbon footprint without loss of asthma control, a post-hoc analysis of the Salford Lung Study in Asthma, has suggested. The analysis, funded by the pharmaceutical company GlaxoSmithKline, was based on a subset of 2,236 patients from the […]
Full Text 
Sign-in/Register to access full text options
Sign-in/Register to access full text options 
Published version (
Free)
Free) 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a call
